arrow
P

Poulam M. Patel

University of Nottingham
H指数:41
被引数:5,670

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma

MEK抑制剂selumetinib单独或与紫杉醇联合治疗转移性葡萄膜黑色素瘤的三臂随机II期研究

2024-05-012
OAAI
Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions

肾癌的多祖先全基因组关联研究确定了63个易感区域

2024-04-262
PRE
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial (vol 29, pg 1843, 2018)
2019-12-014
OAAI
Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study

转移性葡萄膜黑色素瘤的荟萃分析,以确定无进展和总生存基准: 一项国际罕见癌症倡议 (IRCI) 眼黑色素瘤研究

2019-08-01185
OAAI
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
2018-08-0152
OAAI
Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial
2018-02-2232
OAAI
Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative
2015-02-01103
OAAI